1. Home
  2. TC vs LITS Comparison

TC vs LITS Comparison

Compare TC & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TuanChe Limited

TC

TuanChe Limited

HOLD

Current Price

$1.26

Market Cap

38.8M

ML Signal

HOLD

LITS

Lite Strategy Inc.

HOLD

Current Price

$1.18

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TC
LITS
Founded
2010
2000
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.8M
36.3M
IPO Year
2018
2003

Fundamental Metrics

Financial Performance
Metric
TC
LITS
Price
$1.26
$1.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.7M
729.9K
Earning Date
11-03-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 13.81
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$148,908.44
N/A
Revenue Next Year
$4.24
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.20
$0.69
52 Week High
$19.99
$2.26

Technical Indicators

Market Signals
Indicator
TC
LITS
Relative Strength Index (RSI) 27.44 46.87
Support Level N/A $1.12
Resistance Level $2.69 $1.25
Average True Range (ATR) 0.34 0.07
MACD -0.01 -0.02
Stochastic Oscillator 1.69 14.52

Price Performance

Historical Comparison
TC
LITS

About TC TuanChe Limited

Token Cat Ltd has two reportable business segments: automotive electronics resale business and advertising business. The automotive electronics resale business focuses on sourcing, holding, and reselling automotive electronics products, and includes sales of automotive electronic component equipment and accessories, mainly consisting of communication device and power module. The Company procures products from third-party suppliers and resells them to customers through its sales channels. The advertising business currently consists mainly of proxy advertising services, through which the Company helps clients promote their brands, services and products on third-party online platforms. The automotive electronics resale business segment generates maximum revenue.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients. The company operates in the segments: Digital Asset Treasury Strategy and Development of Pharmaceutical Products.

Share on Social Networks: